PhRMA fires 14 PR firms in review

Share this article:

The Pharmaceutical Research and Manufacturers of America has cut its ties with 14 of the firms handling its state and regional PR as part of a wide-ranging review of its contractors. PhRMA senior vice president, communications Ken Johnson said that while he will not rule out an eventual consolidation, for the moment, the group is just assessing its needs and vendor relationships. "All we're trying to do right now is to make certain that we're getting value out of our contractors," said Johnson. "Over the course of the review, it has become clear that a number of our contractors were being underutilized, and so we ended those relationships." Among the firms pitching for PhRMA business are Edelman, APCO Worldwide and Hill & Knowlton. Fleishman-Hillard, previously in the running, has dropped out due to a client conflict.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...

Xtandi duo boosts rep force for pre-chemo push

Xtandi duo boosts rep force for pre-chemo push

With its label extended to the pre-chemo setting, the prostate cancer drug is poised to reach a new group of urologists, and could upend J&J's Zytiga.